SCHEMBL21904698

SCHEMBL21904698

NS(=O)(=O)C1CC2(CCC2)C1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
APLNR P35414 2/20 0.35
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20609946 0.73 APLNR (0.39) APLNR
SCHEMBL20609919 0.70 CXCR2 (0.30)
SCHEMBL25001313 0.69 APLNR (0.39) APLNRCA1
SCHEMBL18709642 0.69 APLNR (0.33) APLNR
SCHEMBL20609939 0.67 GRM2 (0.32)
SCHEMBL23062926 0.67 APLNR (0.37) APLNRCA1CA2
SCHEMBL20609894 0.66
SCHEMBL20609836 0.66
SCHEMBL14033223 0.64
SCHEMBL244348 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200138811-A1 Chemical Compounds AVISTA PHARMA SOLUTIONS INC (US) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200138811-A1 Chemical Compounds JAK1, JAK3, JAK2 APLNR 3319/4885CA1 3104/4885CA2 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.